Search results
AstraZeneca PLC ADR TradeGate Stock Price Today | NASDAQ AZNPy Live Ticker - Investing.com
Investing.com· 2 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Lung cancer treatment produces progression-free survival results in Phase III trial
Medical Xpress· 2 days agoOsimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective ...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 7 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 1 day agoSenderovitz is working with partners from other pharmaceutical companies, including James...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 21 hours agoEmpaveli recorded sales of $25.6 million in the reported quarter, up 25.5% from the year-ago...
Astra’s Enhertu delays breast cancer in patients with low HER2 levels
WSAU Wausau· 5 days agoBy Deena Beasley (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 3 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased ...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 7 days agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 1 day agoBristol Myers spent $4.1 billion to buy RayzeBio; AstraZeneca paid $2 billion for Fusion...